183 related articles for article (PubMed ID: 34327762)
1. Glycoprotein non-metastatic melanoma protein B functions with growth factor signaling to induce tumorigenesis through its serine phosphorylation.
Wang C; Okita Y; Zheng L; Shinkai Y; Manevich L; Chin JM; Kimura T; Suzuki H; Kumagai Y; Kato M
Cancer Sci; 2021 Oct; 112(10):4187-4197. PubMed ID: 34327762
[TBL] [Abstract][Full Text] [Related]
2. Role of the kringle-like domain in glycoprotein NMB for its tumorigenic potential.
Xie R; Okita Y; Ichikawa Y; Fikry MA; Huynh Dam KT; Tran STP; Kato M
Cancer Sci; 2019 Jul; 110(7):2237-2246. PubMed ID: 31127873
[TBL] [Abstract][Full Text] [Related]
3. Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.
Rose AA; Grosset AA; Dong Z; Russo C; Macdonald PA; Bertos NR; St-Pierre Y; Simantov R; Hallett M; Park M; Gaboury L; Siegel PM
Clin Cancer Res; 2010 Apr; 16(7):2147-56. PubMed ID: 20215530
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein nmb Is Exposed on the Surface of Dormant Breast Cancer Cells and Induces Stem Cell-like Properties.
Chen C; Okita Y; Watanabe Y; Abe F; Fikry MA; Ichikawa Y; Suzuki H; Shibuya A; Kato M
Cancer Res; 2018 Nov; 78(22):6424-6435. PubMed ID: 30224376
[TBL] [Abstract][Full Text] [Related]
5. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
[TBL] [Abstract][Full Text] [Related]
6. GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis.
Maric G; Annis MG; Dong Z; Rose AA; Ng S; Perkins D; MacDonald PA; Ouellet V; Russo C; Siegel PM
Oncogene; 2015 Oct; 34(43):5494-504. PubMed ID: 25772243
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB) and Cancer: A Novel Potential Therapeutic Target.
Taya M; Hammes SR
Steroids; 2018 May; 133():102-107. PubMed ID: 29097143
[TBL] [Abstract][Full Text] [Related]
8. GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.
Wang Z; Ran X; Qian S; Hou H; Dong M; Wu S; Ding M; Zhang Y; Zhang X; Zhang M; Chen Q
Arch Biochem Biophys; 2021 Oct; 710():108998. PubMed ID: 34280359
[TBL] [Abstract][Full Text] [Related]
9. N-glycosylated GPNMB ligand independently activates mutated EGFR signaling and promotes metastasis in NSCLC.
Han CL; Chen XR; Lan A; Hsu YL; Wu PS; Hung PF; Hung CL; Pan SH
Cancer Sci; 2021 May; 112(5):1911-1923. PubMed ID: 33706413
[TBL] [Abstract][Full Text] [Related]
10. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells.
Cross MJ; Lu L; Magnusson P; Nyqvist D; Holmqvist K; Welsh M; Claesson-Welsh L
Mol Biol Cell; 2002 Aug; 13(8):2881-93. PubMed ID: 12181353
[TBL] [Abstract][Full Text] [Related]
11. ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties.
Rose AA; Annis MG; Dong Z; Pepin F; Hallett M; Park M; Siegel PM
PLoS One; 2010 Aug; 5(8):e12093. PubMed ID: 20711474
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of bladder cancer cells through its hem-immunoreceptor tyrosine-based activation motif.
Kimura T; Okita Y; Nagumo Y; Chin JM; Fikry MA; Shiga M; Kandori S; Kawahara T; Suzuki H; Nishiyama H; Kato M
Pathol Int; 2024 May; 74(5):262-273. PubMed ID: 38501371
[TBL] [Abstract][Full Text] [Related]
13. The laminin-derived peptide C16 regulates GPNMB expression and function in breast cancer.
Smuczek B; Santos ES; Siqueira AS; Pinheiro JJV; Freitas VM; Jaeger RG
Exp Cell Res; 2017 Sep; 358(2):323-334. PubMed ID: 28689015
[TBL] [Abstract][Full Text] [Related]
14. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase B activation and lamellipodium formation are independent phosphoinositide 3-kinase-mediated events differentially regulated by endogenous Ras.
van Weering DH; de Rooij J; Marte B; Downward J; Bos JL; Burgering BM
Mol Cell Biol; 1998 Apr; 18(4):1802-11. PubMed ID: 9528752
[TBL] [Abstract][Full Text] [Related]
16. GPNMB enhances bone regeneration by promoting angiogenesis and osteogenesis: potential role for tissue engineering bone.
Hu X; Zhang P; Xu Z; Chen H; Xie X
J Cell Biochem; 2013 Dec; 114(12):2729-37. PubMed ID: 23794283
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB.
Okita Y; Kimura M; Xie R; Chen C; Shen LT; Kojima Y; Suzuki H; Muratani M; Saitoh M; Semba K; Heldin CH; Kato M
Sci Signal; 2017 Apr; 10(474):. PubMed ID: 28400538
[TBL] [Abstract][Full Text] [Related]
18. Kinase suppressor of Ras signals through Thr269 of c-Raf-1.
Xing HR; Kolesnick R
J Biol Chem; 2001 Mar; 276(13):9733-41. PubMed ID: 11134016
[TBL] [Abstract][Full Text] [Related]
19. By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis.
Gao J; Liu X; Yang F; Liu T; Yan Q; Yang X
Oncotarget; 2015 Sep; 6(29):27187-98. PubMed ID: 26356670
[TBL] [Abstract][Full Text] [Related]
20. GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity.
Fiorentini C; Bodei S; Bedussi F; Fragni M; Bonini SA; Simeone C; Zani D; Berruti A; Missale C; Memo M; Spano P; Sigala S
Exp Cell Res; 2014 Apr; 323(1):100-111. PubMed ID: 24589892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]